Deepak Chadha serves as Executive at Brickell Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Deepak Chadha has executed 7 insider transactions totaling $12.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 1, 2023 involved selling 14,978 shares valued at $9.3K.
Deepak Chadha currently holds 22,314 shares of Brickell Biotech, Inc. (BBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Deepak Chadha has been a net buyer of BBI stock. They have purchased $12.6K and sold $0 worth of shares.
Deepak Chadha's most recent insider trade was on Sep 1, 2023, when they sold 14,978 shares at $0.62 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 19, 2021 | BBI | $10.4K | Purchase | 12,500 | $0.83 | Discretionary |
| May 18, 2021 | BBI | $2.2K | Purchase | 2,700 | $0.82 | Discretionary |
| Mar 16, 2021 | BBI | $0 | Option Exercise | 25,000 | $N/A | Discretionary |
| Mar 16, 2021 | BBI | $10.0K | Payment | 8,750 | $1.14 | Discretionary |
| Jun 22, 2020 | BBI | $0 | Purchase | 26,087 | $N/A | Discretionary |